FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013722350> ?p ?o ?g. }

• W3013722350 abstract "Background: MicroRNA-143(miR-143) is known to function as the tumor suppressor in various cancers, including breast cancer. The tumor immune microenvironment such as the balance between the T helper cell type 1 (Th1) and Th2 is reported to associate with the survival of the breast cancer patients. In this study, we hypothesized that the miR-143 has favorable effect to the tumor immune microenvironment. Material and Methods: We obtained the clinicopathological data and survival information of 755 breast cancer patients from The Cancer Genome Atlas (TCGA) database. Survival analysis, Overall survival (OS) and Disease free survival (DFS) was conducted comparing the high and low expression groups. CYT score, CIBERSORT, and other immunological factors were used to evaluate intratumoral immune cell composition within estrogen receptor (ER) positive breast cancer patients. Also, gene set enrichment analysis (GSEA) was performed between miR-143 high and low expression groups within the ER positive group. Results: High expression of miR-143 was significantly associated with prolonged OS only in ER positive breast cancer patients (p=0.014). Expression of miR-143 was not associated with DFS, stage, TNM factors of breast cancer patients. Within ER positive patients, the result of CIBERSORT revealed that high expression of miR-143 was associated with higher percentage of macrophage M1 (p Conclusion: High expression of miR-143 was associated with improved OS in ER positive breast cancer patients. Also, miR-143 was found to associate with high Th1 and low Th2 cells as well as enriching the genes relating to Th1 cells, which may explain the favorable role of miR-143 in ER positive breast cancer. Citation Format: Yoshihisa Tokumaru, Masanori Oshi, Mariko Asaoka, Takashi Takeshita, Eriko Katsuta, Manabu Futamura, Kazuhiro Yoshida, Kazuaki Takabe. High expression microRNA-143 is associated with favorable tumor immune microenvironment and better survival of ER positive breast cancer patients [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P3-08-59." @default.
• W3013722350 created "2020-04-03" @default.
• W3013722350 creator A5029088912 @default.
• W3013722350 creator A5041026823 @default.
• W3013722350 creator A5057255416 @default.
• W3013722350 creator A5067561532 @default.
• W3013722350 creator A5079949414 @default.
• W3013722350 creator A5081174788 @default.
• W3013722350 creator A5087154078 @default.
• W3013722350 creator A5090406100 @default.
• W3013722350 date "2020-02-14" @default.
• W3013722350 modified "2023-09-27" @default.
• W3013722350 title "Abstract P3-08-59: High expression microRNA-143 is associated with favorable tumor immune microenvironment and better survival of ER positive breast cancer patients" @default.
• W3013722350 doi "https://doi.org/10.1158/1538-7445.sabcs19-p3-08-59" @default.
• W3013722350 hasPublicationYear "2020" @default.
• W3013722350 type Work @default.
• W3013722350 sameAs 3013722350 @default.
• W3013722350 citedByCount "0" @default.
• W3013722350 crossrefType "proceedings-article" @default.
• W3013722350 hasAuthorship W3013722350A5029088912 @default.
• W3013722350 hasAuthorship W3013722350A5041026823 @default.
• W3013722350 hasAuthorship W3013722350A5057255416 @default.
• W3013722350 hasAuthorship W3013722350A5067561532 @default.
• W3013722350 hasAuthorship W3013722350A5079949414 @default.
• W3013722350 hasAuthorship W3013722350A5081174788 @default.
• W3013722350 hasAuthorship W3013722350A5087154078 @default.
• W3013722350 hasAuthorship W3013722350A5090406100 @default.
• W3013722350 hasConcept C104317684 @default.
• W3013722350 hasConcept C121608353 @default.
• W3013722350 hasConcept C126322002 @default.
• W3013722350 hasConcept C143998085 @default.
• W3013722350 hasConcept C145059251 @default.
• W3013722350 hasConcept C203014093 @default.
• W3013722350 hasConcept C2776107976 @default.
• W3013722350 hasConcept C502942594 @default.
• W3013722350 hasConcept C530470458 @default.
• W3013722350 hasConcept C55493867 @default.
• W3013722350 hasConcept C71924100 @default.
• W3013722350 hasConcept C84606932 @default.
• W3013722350 hasConcept C86803240 @default.
• W3013722350 hasConcept C8891405 @default.
• W3013722350 hasConceptScore W3013722350C104317684 @default.
• W3013722350 hasConceptScore W3013722350C121608353 @default.
• W3013722350 hasConceptScore W3013722350C126322002 @default.
• W3013722350 hasConceptScore W3013722350C143998085 @default.
• W3013722350 hasConceptScore W3013722350C145059251 @default.
• W3013722350 hasConceptScore W3013722350C203014093 @default.
• W3013722350 hasConceptScore W3013722350C2776107976 @default.
• W3013722350 hasConceptScore W3013722350C502942594 @default.
• W3013722350 hasConceptScore W3013722350C530470458 @default.
• W3013722350 hasConceptScore W3013722350C55493867 @default.
• W3013722350 hasConceptScore W3013722350C71924100 @default.
• W3013722350 hasConceptScore W3013722350C84606932 @default.
• W3013722350 hasConceptScore W3013722350C86803240 @default.
• W3013722350 hasConceptScore W3013722350C8891405 @default.
• W3013722350 hasLocation W30137223501 @default.
• W3013722350 hasOpenAccess W3013722350 @default.
• W3013722350 hasPrimaryLocation W30137223501 @default.
• W3013722350 hasRelatedWork W10138567 @default.
• W3013722350 hasRelatedWork W10381122 @default.
• W3013722350 hasRelatedWork W11893065 @default.
• W3013722350 hasRelatedWork W12019937 @default.
• W3013722350 hasRelatedWork W12242190 @default.
• W3013722350 hasRelatedWork W12336852 @default.
• W3013722350 hasRelatedWork W14542699 @default.
• W3013722350 hasRelatedWork W19676875 @default.
• W3013722350 hasRelatedWork W2083469 @default.
• W3013722350 hasRelatedWork W718895 @default.
• W3013722350 isParatext "false" @default.
• W3013722350 isRetracted "false" @default.
• W3013722350 magId "3013722350" @default.
• W3013722350 workType "article" @default.